FDAnews Device Daily Bulletin
Jan. 3, 2005 | Vol. 2 No. 1
Cardiff, Wales-based Q Chip has signed a new research deal with Biocompatibles International, a medical device company focused on the treatment of cardiovascular disease, cancer and benign tumors.
Tel Aviv, Israel-based Elron Electronic Industries has completed a new $7.3 million investment in Impliant as part of an $18 million financing round from new and existing investors.
ThyroTest, a new rapid hypothyroid diagnostic screening device from ThyroTec, received FDA approval for the detection of hypothyroidism.
Xillix Technologies, a Canadian medical device company specializing in fluorescence endoscopy for improved cancer detection, has closed a private placement of $5 million of convertible, unsecured debentures of Xillix Ltd., a wholly owned Toronto-based subsidiary of the company.
ForHealth Technologies has successfully completed the transition for the manufacture of its flagship robotic technology IntelliFill i.v. from a California-based contract manufacturer to Delphi Medical Systems. IntelliFill i.v. automates the compounding and labeling of intravenous doses in syringes at speeds that can only be achieved through automated processes.
Alfresa Holdings has announced its subsidiary Alfresa Pharma launched the Hemotect NS-Plus C, an automated immunochemical analyzer, and its proprietary reagent Nescoat HemoPlus for fecal occult blood tests.
Lifecore Biomedical has renewed its supply agreement with global eye care company Alcon.
Sigma has launched a new whole genome amplification (WGA) kit, GenomePlex WGA.
The Purdue Research Foundation partnered with Memphis, Tenn.-based Medtronic Sofamor Danek to commercialize technology discovered at Purdue University that may someday prevent paralysis in humans with spinal cord injuries.
SonoSite has announced it began customer shipments of the SonoCalc IMT software, allowing physicians to quickly and effectively measure the wall thickness (IMT) of the common carotid arteries and assess a patient's risk of cardiovascular disease.
Windsor, Conn.-based Scapa Medical has announced Bioflex Rx232V-60, a single coated medical grade polyethylene foam adhesive for use in medical device assembly or direct skin contact applications.
Los Angeles, Calif.-based Diagnostic Products promoted Sidney Aroesty, the company's senior vice president of operations and chief operating officer, to the additional post of president.
Curon Medical, a developer, manufacturer and marketer of radiofrequency generators and single use disposable devices, announced that on Dec. 22 the Nasdaq Listing Qualifications Department notified the company that as a result of Alan Kaganov's Dec. 1 resignation from the board of directors, the corporation was no longer in compliance with Nasdaq's audit committee composition requirement because it did not have the requisite number of directors serving on its audit committee.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.